Royal Philips NV’s $1.1 billion settlement of US lawsuits targeting 5.5 million recalled sleep-apnea devices resolves only current cases and doesn’t set aside monies for potential future cancer claims over the machines.
(Bloomberg) — Royal Philips NV’s $1.1 billion settlement of US lawsuits targeting 5.5 million recalled sleep-apnea devices resolves only current cases and doesn’t set aside monies for potential future cancer claims over the machines. Read More
Related
Share this page
Guest Posts by Easy Branches
